Elite Pharmaceuticals, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Elite Pharmaceuticals, Inc. (ELTP) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-06-30 was $0.10.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2016-06-30 was $0.10.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2026 was $0.04, a 80.95% decline from fiscal 2025.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.21.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $0.21, a 75.00% increase from fiscal 2015.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $0.12, a 50.00% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.10 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.04 10-K · filed 2026-06-29 | |||
| 2025-12-31 | $0.04 10-Q · filed 2026-02-17 | |||
| 2025-09-30 | $0.03 10-Q · filed 2025-11-14 | |||
| 2025-03-31 | $0.21 10-K · filed 2025-06-30 | |||
| 2016-12-31 | $0.09 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | $0.10 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $0.10 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $0.21 10-K · filed 2016-06-15 | |||
| 2015-03-31 | $0.12 10-K · filed 2016-06-15 | |||
| 2014-03-31 | $0.08 10-K · filed 2016-06-15 | |||
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 | |||
| 2012-03-31 | $0.00 10-K · filed 2013-06-21 |